You have no items in your shopping cart.
Brand Name : Eptide 0.75mg Infusion
Composition : Eptifibatide (0.75mg)
Manufactured By : Sun Pharmaceutical Industries Ltd
Form : vial
Packing : 100 ml in 1 bottle
Save an Extra $25 on Every Buy!
Valid for all users
Eptide 0.75mg Infusion Description:
Eptide 0.75mg Infusion is an antiplatelet medication. It works by preventing platelets from sticking together which decreases the formation of harmful blood clots.
Eptide 0.75mg Infusion is used in the treatment of unstable angina.
Bleeding, Decreased blood pressure.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Is Eptide a thrombolytic agent/ what is Eptide infusion/ how does Eptide work?
Eptide is a thrombolytic drug and belongs to a class of drugs called Glycoprotein IIb/IIIa inhibitors. It works by inhibiting platelet aggregation and thus prevents blockage of blood vessels due to formation of blood clots.
Buy Eptide 0.75mg Infusion Online From India At Best Price
If you are looking to buy Eptifibatide (0.75mg) (100 ml in 1 bottle) online at affordable prices, then Drugssquare.com is your one-stop solution. Drugssquare is a leading supplier, exporter and retailer of generic & branded prescription drugs in the U.S. and all around the world. From Cancer to Hepatitis, and from AIDS to Kidney Disease, the company delivers medicines for all kinds of complex diseases, with savings of up to 70% or more.
Order Online to Get Eptide 0.75mg Infusion in -
South East Asia - China, Cambodia, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Hong Kong, Japan, South Korea.
United Arab Emirates (UAE) - Iran, Saudi Arabia, Jordan.
North America - Venezuela, USA (United States of America), Suriname.
South America - Argentina, Chile, Colombia, Peru, Venezuela.
Europe - Romania, Georgia, Turkey, UK (United Kingdom), Ukraine, Latvia.
Russia CIS - Moldova, Uzbekistan, Kyrgyzstan.
African Countries - Nigeria, Kenya, Morocco, Libya, Zimbabwe.
Other Countries - Malaysia, Egypt, Australia, Italy and New Zealand.